HMGB1: a two-headed signal regulating tumor progression and immunity

Lara Campana, Lidia Bosurgi, Patrizia Rovere-Querini

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Cells of the innate immune system sense tissue damage recognizing in the extracellular environment bona fide intracellular moieties, like high mobility group box 1 (HMGB1). In the case of tumors, HMGB1 recognition has a paradoxical dual effect: it promotes tumor neoangiogenesis and triggers protective anti-neoplastic T-cell responses. Recent advances in the study of HMGB1 have identified candidate molecular mechanisms underlying these apparently contrasting outcomes. A surprising role for innate receptors, including toll like receptor 4 (TLR4), in the response to conventional cancer radio and chemotherapy has also recently emerged, providing new insight into the mechanisms by which these treatments actually work.

Original languageEnglish
Pages (from-to)518-523
Number of pages6
JournalCurrent Opinion in Immunology
Volume20
Issue number5
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Immunity
Neoplasms
Toll-Like Receptor 4
Radio
Immune System
T-Lymphocytes
Drug Therapy
Therapeutics
Thomsen-Friedenreich antibodies

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

HMGB1 : a two-headed signal regulating tumor progression and immunity. / Campana, Lara; Bosurgi, Lidia; Rovere-Querini, Patrizia.

In: Current Opinion in Immunology, Vol. 20, No. 5, 10.2008, p. 518-523.

Research output: Contribution to journalArticle

@article{f26aec445afa41cdae472a27a963784e,
title = "HMGB1: a two-headed signal regulating tumor progression and immunity",
abstract = "Cells of the innate immune system sense tissue damage recognizing in the extracellular environment bona fide intracellular moieties, like high mobility group box 1 (HMGB1). In the case of tumors, HMGB1 recognition has a paradoxical dual effect: it promotes tumor neoangiogenesis and triggers protective anti-neoplastic T-cell responses. Recent advances in the study of HMGB1 have identified candidate molecular mechanisms underlying these apparently contrasting outcomes. A surprising role for innate receptors, including toll like receptor 4 (TLR4), in the response to conventional cancer radio and chemotherapy has also recently emerged, providing new insight into the mechanisms by which these treatments actually work.",
author = "Lara Campana and Lidia Bosurgi and Patrizia Rovere-Querini",
year = "2008",
month = "10",
doi = "10.1016/j.coi.2008.04.012",
language = "English",
volume = "20",
pages = "518--523",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - HMGB1

T2 - a two-headed signal regulating tumor progression and immunity

AU - Campana, Lara

AU - Bosurgi, Lidia

AU - Rovere-Querini, Patrizia

PY - 2008/10

Y1 - 2008/10

N2 - Cells of the innate immune system sense tissue damage recognizing in the extracellular environment bona fide intracellular moieties, like high mobility group box 1 (HMGB1). In the case of tumors, HMGB1 recognition has a paradoxical dual effect: it promotes tumor neoangiogenesis and triggers protective anti-neoplastic T-cell responses. Recent advances in the study of HMGB1 have identified candidate molecular mechanisms underlying these apparently contrasting outcomes. A surprising role for innate receptors, including toll like receptor 4 (TLR4), in the response to conventional cancer radio and chemotherapy has also recently emerged, providing new insight into the mechanisms by which these treatments actually work.

AB - Cells of the innate immune system sense tissue damage recognizing in the extracellular environment bona fide intracellular moieties, like high mobility group box 1 (HMGB1). In the case of tumors, HMGB1 recognition has a paradoxical dual effect: it promotes tumor neoangiogenesis and triggers protective anti-neoplastic T-cell responses. Recent advances in the study of HMGB1 have identified candidate molecular mechanisms underlying these apparently contrasting outcomes. A surprising role for innate receptors, including toll like receptor 4 (TLR4), in the response to conventional cancer radio and chemotherapy has also recently emerged, providing new insight into the mechanisms by which these treatments actually work.

UR - http://www.scopus.com/inward/record.url?scp=50549094596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50549094596&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2008.04.012

DO - 10.1016/j.coi.2008.04.012

M3 - Article

C2 - 18599281

AN - SCOPUS:50549094596

VL - 20

SP - 518

EP - 523

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 5

ER -